Physician profile
Daniel C Sun
NPI 1083097497
$12,499.43
in general payments reported to CMS, 2019-2025
12 companies · $2,898 in 2025
The $2,898 reported for 2025 was more than what 76% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,799 · 2020: $1,019 · 2021: $2,754 · 2022: $558 · 2023: $514 · 2024: $959 · 2025: $2,898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,913 · Travel and Lodging: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,913.49 |
| Travel and Lodging | $1,456.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,097.22 | 2019-2025 | Mako, Triathlon, Insignia |
| Encore Medical, Lp | $1,567.73 | 2020-2021 | |
| Exactech, INC. | $951.90 | 2019 | |
| Zimmer Biomet Holdings, INC. | $665.93 | 2019-2025 | G7, Persona, Trabecular Metal |
| Depuy Synthes Sales INC. | $565.98 | 2019-2021 | |
| Smith+Nephew, INC. | $363.77 | 2022-2025 | Evos, Redapt, Real Intelligence |
| Heraeus Medical, LLC. | $86.27 | 2019 | |
| Acera Surgical, INC. | $51.90 | 2025 | Restrata Wound Matrix |
| Aroa Biosurgery Incorporated | $42.11 | 2025 | |
| Conformis, INC. | $41.10 | 2021 | |
| Bioventus LLC | $38.79 | 2025 | Durolane |
| Polynovo North America LLC | $26.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.